Hoefs J C
J Lab Clin Med. 1983 Aug;102(2):260-73.
The ascitic fluid and serum concentrations of albumin and globulin were measured simultaneously with transhepatic portal pressure determination in 56 patients with chronic liver disease to determine whether (1) portal pressure correlated with (S-Asc)A and (2) the majority of variation in ascitic fluid protein concentration between patients was related to fluid balance from serum to ascites. The mean ascitic fluid albumin concentration was 1.04 +/- 0.73 gm/dl; globulin concentration 1.31 +/- 0.80 gm/dl; and ascitic fluid total protein concentration 2.35 +/- 1.49 gm/dl. The mean serum albumin concentration was 2.58 +/- .57 gm/dl; globulin concentration 3.91 +/- .86 gm/dl; and total protein concentration 6.49 +/- 1.30 gm/dl. The (S-Asc)A was 1.54 +/- .45 gm/dl. The mean PPIVC was 14.5 +/- 4.3 mm Hg. The (S-Asc)A correlated directly with PPIVC (r = 0.73; p less than 0.0001). The ascitic fluid protein correlated with three variables that did not correlate with each other: serum albumin (r = 0.67; p less than 0.0001), serum globulin (r = 0.44; p less than 0.001), and PPIVC (r = -0.48; p less than 0.0005). The sum of the squared correlation coefficients with these latter uncorrelated variables equaled 0.87 and partial correlation coefficient analyses demonstrated an increase in the correlation of the ascitic fluid protein with the serum albumin concentration when corrected for serum globulin and (S-Asc)A (r = 0.97; p less than 0.0001) or PPIVC (r = 0.90; p less than 0.0001). Thus most of the variation in ascitic fluid protein between patients in this study could be related to serum protein concentrations and PPIVC or (S-Asc)A. Furthermore, multivariate discriminant analysis of patients with an ascitic fluid protein less than or equal to 2.5 vs. greater than 2.5 gm/dl indicated that the majority of differences between the two groups could be attributed to differences in serum albumin and serum globulin in combination with the (S-Asc)A (canonical correlation = 0.808) or PPIVC (canonical correlation = 0.806). These factors could correctly identify the low or high ascitic fluid protein groups in 96% and 93% of patients, respectively.
(1) the (S-Asc)A is associated with the degree of portal pressure elevation and (2) the majority of variation in ascitic fluid protein concentration between patients with chronic liver disease is associated with differences in portal pressure and serum protein concentrations.
对56例慢性肝病患者同时测定腹水和血清中的白蛋白及球蛋白浓度,并测定经肝门静脉压力,以确定:(1)门静脉压力是否与(血清-腹水)白蛋白梯度相关;(2)患者腹水蛋白浓度的大部分差异是否与血清至腹水的液体平衡有关。腹水白蛋白平均浓度为1.04±0.73g/dl;球蛋白浓度为1.31±0.80g/dl;腹水总蛋白浓度为2.35±1.49g/dl。血清白蛋白平均浓度为2.58±0.57g/dl;球蛋白浓度为3.91±0.86g/dl;总蛋白浓度为6.49±1.30g/dl。(血清-腹水)白蛋白梯度为1.54±0.45g/dl。门静脉压平均为14.5±4.3mmHg。(血清-腹水)白蛋白梯度与门静脉压呈正相关(r = 0.73;p<0.0001)。腹水蛋白与三个互不相关的变量相关:血清白蛋白(r = 0.67;p<0.0001)、血清球蛋白(r = 0.44;p<0.001)和门静脉压(r = -0.48;p<0.0005)。与这些不相关变量的平方相关系数之和为0.87,偏相关系数分析表明,校正血清球蛋白和(血清-腹水)白蛋白梯度后,腹水蛋白与血清白蛋白浓度的相关性增加(r = 0.97;p<0.0001)或与门静脉压的相关性增加(r = 0.90;p<0.0001)。因此,本研究中患者腹水蛋白的大部分差异可能与血清蛋白浓度以及门静脉压或(血清-腹水)白蛋白梯度有关。此外,对腹水蛋白≤2.5g/dl与>2.5g/dl的患者进行多变量判别分析表明,两组之间的大部分差异可归因于血清白蛋白和血清球蛋白与(血清-腹水)白蛋白梯度(典型相关系数 = 0.808)或门静脉压(典型相关系数 = 0.806)的联合作用。这些因素分别能正确识别96%和93%的腹水蛋白低或高的患者组。
(1)(血清-腹水)白蛋白梯度与门静脉压力升高程度相关;(2)慢性肝病患者腹水蛋白浓度的大部分差异与门静脉压力和血清蛋白浓度的差异有关。